Ignite Creation Date:
2025-12-24 @ 10:16 PM
Ignite Modification Date:
2026-01-01 @ 4:06 PM
Study NCT ID:
NCT05105035
Status:
COMPLETED
Last Update Posted:
2024-02-16
First Post:
2021-09-23
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Oral ARV-1801 Given in Combination With Intravenous Ceftazidime or Meropenem for Treatment of Melioidosis in Hospitalized Patients
Sponsor:
Arrevus Inc.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2022-06-14
Start Date Type:
ACTUAL
Primary Completion Date:
2023-10-10
Primary Completion Date Type:
ACTUAL
Completion Date:
2023-10-10
Completion Date Type:
ACTUAL
First Submit Date:
2021-09-23
First Submit QC Date:
None
Study First Post Date:
2021-11-03
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-02-14
Last Update Post Date:
2024-02-16
Last Update Post Date Type:
ACTUAL